Vicki L Wheelock

Title(s)Professor, Med: Neurology
SchoolSchool of Medicine
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Tominersen in Adults with Manifest Huntington's Disease. N Engl J Med. 2023 12 07; 389(23):2203-2205. McColgan P, Thobhani A, Boak L, Schobel SA, Nicotra A, Palermo G, Trundell D, Zhou J, Schlegel V, Sanwald Ducray P, Hawellek DJ, Dorn J, Simillion C, Lindemann M, Wheelock V, Durr A, Anderson KE, Long JD, Wild EJ, Landwehrmeyer GB, Leavitt BR, Tabrizi SJ, Doody R, GENERATION HD1 Investigators. PMID: 38055260.
      View in: PubMed   Mentions: 25     Fields:    
    2. Sex differences in Parkinson disease-associated episodic memory and processing speed deficits. J Int Neuropsychol Soc. 2023 11; 29(9):813-820. Reekes TH, Higginson CI, Sigvardt KA, King DS, Levine D, Wheelock VL, Disbrow EA. PMID: 36971238.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    3. Translating cell therapies for neurodegenerative diseases: Huntington's disease as a model disorder. Brain. 2022 06 03; 145(5):1584-1597. Rosser AE, Busse ME, Gray WP, Badin RA, Perrier AL, Wheelock V, Cozzi E, Martin UP, Salado-Manzano C, Mills LJ, Drew C, Goldman SA, Canals JM, Thompson LM. PMID: 35262656; PMCID: PMC9166564.
      View in: PubMed   Mentions: 5     Fields:    
    4. Cell Therapy for Huntington's Disease: Learning from Failure. Mov Disord. 2021 03; 36(3):787-788. Rosser AE, Busse M, Aron Badin R, Canals JM, Wheelock V, Perrier AL, Gray W, Thompson L, Goldman S. PMID: 33749919; PMCID: PMC8506258.
      View in: PubMed   Mentions: 1     Fields:    
    5. Subdural Hematoma as a Serious Complication of Huntington's Disease: An Observational Study. J Huntingtons Dis. 2021; 10(3):385-390. Davis M, Wheelock V, Talman L, Latimer C, Vicars B, Lin A, Jayadev S, Bird T. PMID: 34366363.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease. Neurol Genet. 2020 Jun; 6(3):e430. Claassen DO, Corey-Bloom J, Dorsey ER, Edmondson M, Kostyk SK, LeDoux MS, Reilmann R, Rosas HD, Walker F, Wheelock V, Svrzikapa N, Longo KA, Goyal J, Hung S, Panzara MA. PMID: 32548276; PMCID: PMC7249892.
      View in: PubMed   Mentions: 4  
    7. Atypical antipsychotic therapy in Parkinson's disease psychosis: A retrospective study. Brain Behav. 2017 06; 7(6):e00639. Yuan M, Sperry L, Malhado-Chang N, Duffy A, Wheelock V, Farias S, O'Connor K, Olichney J, Shahlaie K, Zhang L. PMID: 28638698; PMCID: PMC5474696.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    8. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. 2017 Jan 10; 88(2):152-159. McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, Rosas HD, Nance M, Biglan K, Como P, Dubinsky RM, Shannon KM, O'Suilleabhain P, Chou K, Walker F, Martin W, Wheelock VL, McCusker E, Jankovic J, Singer C, Sanchez-Ramos J, Scott B, Suchowersky O, Factor SA, Higgins DS, Molho E, Revilla F, Caviness JN, Friedman JH, Perlmutter JS, Feigin A, Anderson K, Rodriguez R, McFarland NR, Margolis RL, Farbman ES, Raymond LA, Suski V, Kostyk S, Colcher A, Seeberger L, Epping E, Esmail S, Diaz N, Fung WL, Diamond A, Frank S, Hanna P, Hermanowicz N, Dure LS, Cudkowicz M, Huntington Study Group 2CARE Investigators and Coordinators. PMID: 27913695; PMCID: PMC5224719.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    9. Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease Fibroblasts. Cell Transplant. 2016; 25(4):677-86. Fink KD, Deng P, Gutierrez J, Anderson JS, Torrest A, Komarla A, Kalomoiris S, Cary W, Anderson JD, Gruenloh W, Duffy A, Tempkin T, Annett G, Wheelock V, Segal DJ, Nolta JA. PMID: 26850319; PMCID: PMC6476541.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    10. Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models. Mol Ther. 2016 05; 24(5):965-77. Pollock K, Dahlenburg H, Nelson H, Fink KD, Cary W, Hendrix K, Annett G, Torrest A, Deng P, Gutierrez J, Nacey C, Pepper K, Kalomoiris S, D Anderson J, McGee J, Gruenloh W, Fury B, Bauer G, Duffy A, Tempkin T, Wheelock V, Nolta JA. PMID: 26765769; PMCID: PMC4881765.
      View in: PubMed   Mentions: 94     Fields:    
    11. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. JAMA Neurol. 2016 Jan; 73(1):102-10. Huntington Study Group PHAROS Investigators, Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, Siemers E, Tanner C, Mallonee W, Suter G, Dubinsky R, Gray C, Nance M, Bundlie S, Radtke D, Kostyk S, Baic C, Caress J, Walker F, Hunt V, O'Neill C, Chouinard S, Factor S, Greenamyre T, Wood-Siverio C, Corey-Bloom J, Song D, Peavy G, Moskowitz C, Wesson M, Samii A, Bird T, Lipe H, Blindauer K, Marshall F, Zimmerman C, Goldstein J, Rosas D, Novak P, Caviness J, Adler C, Duffy A, Wheelock V, Tempkin T, Richman D, Seeberger L, Albin R, Chou KL, Racette B, Perlmutter JS, Perlman S, Bordelon Y, Martin W, Wieler M, Leavitt B, Raymond L, Decolongon J, Clarke L, Jankovic J, Hunter C, Hauser RA, Sanchez-Ramos J, Furtado S, Suchowersky O, Klimek ML, Guttman M, Sethna R, Feigin A, Cox M, Shannon B, Percy A, Dure L, Harrison M, Johnson W, Higgins D, Molho E, Nickerson C, Evans S, Hobson D, Singer C, Galvez-Jimenez N, Shannon K, Comella C, Ross C, Saint-Hilaire MH, Testa C, Rosenblatt A, Hogarth P, Weiner W, Como P, Kumar R, Cotto C, Stout J, Brocht A, Watts A, Eberly S, Weaver C, Foroud T, Gusella J, MacDonald M, Myers R, Fahn S, Shults C. PMID: 26569098.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    12. The impact of oculomotor functioning on neuropsychological performance in Huntington disease. J Clin Exp Neuropsychol. 2016; 38(2):217-26. Carvalho JO, Long JD, Westervelt HJ, Smith MM, Bruce JM, Kim JI, Mills JA, Paulsen JS, PREDICT-HD Investigators And Coordinators Of The Huntington Study Group. PMID: 26745770; PMCID: PMC8091165.
      View in: PubMed   Mentions: 3     Fields:    
    13. Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD. Mov Disord. 2015 Oct; 30(12):1664-72. Long JD, Paulsen JS, PREDICT-HD Investigators and Coordinators of the Huntington Study Group. PMID: 26340420; PMCID: PMC4795466.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    14. Prefrontal cortex white matter tracts in prodromal Huntington disease. Hum Brain Mapp. 2015 Oct; 36(10):3717-32. Matsui JT, Vaidya JG, Wassermann D, Kim RE, Magnotta VA, Johnson HJ, Paulsen JS, PREDICT-HD Investigators and Coordinators of the Huntington Study Group. PMID: 26179962; PMCID: PMC4583330.
      View in: PubMed   Mentions: 19     Fields:    
    15. Multivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease. Neuropsychology. 2015 Nov; 29(6):949-60. Kim JI, Long JD, Mills JA, McCusker E, Paulsen JS, PREDICT-HD Investigators and Coordinators of the Huntington Study Group. PMID: 26011117; PMCID: PMC4640959.
      View in: PubMed   Mentions: 4     Fields:    
    16. Intra-individual Variability in Prodromal Huntington Disease and Its Relationship to Genetic Burden. J Int Neuropsychol Soc. 2015 Jan; 21(1):8-21. Musso M, Westervelt HJ, Long JD, Morgan E, Woods SP, Smith MM, Lu W, Paulsen JS, PREDICT-HD Investigators of the Huntington Study Group. PMID: 26304055; PMCID: PMC4549971.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    17. Developing stem cell therapies for juvenile and adult-onset Huntington's disease. Regen Med. 2015; 10(5):623-46. Fink KD, Deng P, Torrest A, Stewart H, Pollock K, Gruenloh W, Annett G, Tempkin T, Wheelock V, Nolta JA. PMID: 26237705; PMCID: PMC6785015.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    18. Subjective Cognitive Complaints in Parkinson Disease Without Dementia: A Preliminary Study. Appl Neuropsychol Adult. 2015; 22(4):287-92. Koster DP, Higginson CI, MacDougall EE, Wheelock VL, Sigvardt KA. PMID: 25495957.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    19. A case of familial ALS due to multi-system proteinopathy 1 and Huntington disease. Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar; 16(1-2):124-6. Oskarsson B, Wheelock V, Benatar M, Taylor JP, Joyce N, Chesak D, Jin LW. PMID: 25205077; PMCID: PMC4664522.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    20. Tracking motor impairments in the progression of Huntington's disease. Mov Disord. 2014 Mar; 29(3):311-9. Long JD, Paulsen JS, Marder K, Zhang Y, Kim JI, Mills JA, Researchers of the PREDICT-HD Huntington's Study Group. PMID: 24150908; PMCID: PMC4219558.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    21. Teaching neuroimages: fungus in the brain: coccidioidomycosis meningoencephalitis. Neurology. 2013 Feb 19; 80(8):e82. Goldenholz DM, Mehra N, Dahlin B, Cohen SH, Wheelock VL. PMID: 23420900.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Regional atrophy associated with cognitive and motor function in prodromal Huntington disease. J Huntingtons Dis. 2013; 2(4):477-89. Aylward EH, Harrington DL, Mills JA, Nopoulos PC, Ross CA, Long JD, Liu D, Westervelt HK, Paulsen JS, PREDICT-HD Investigators and Coordinators of the Huntington Study Group. PMID: 25062732; PMCID: PMC4412155.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    23. Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis. Hum Brain Mapp. 2014 Mar; 35(3):792-809. Younes L, Ratnanather JT, Brown T, Aylward E, Nopoulos P, Johnson H, Magnotta VA, Paulsen JS, Margolis RL, Albin RL, Miller MI, Ross CA, PREDICT-HD Investigators and Coordinators of the Huntington Study Group. PMID: 23281100; PMCID: PMC3715588.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    24. Development of the Huntington disease work function scale. J Occup Environ Med. 2012 Oct; 54(10):1300-8. Brossman B, Williams JK, Downing N, Mills JA, Paulsen JS, PREDICT-HD Investigators and Coordinators of the Huntington Study Group. PMID: 22995807; PMCID: PMC3466392.
      View in: PubMed   Mentions: 4     Fields:    
    25. Treatment of γ-aminobutyric acid B receptor-antibody autoimmune encephalitis with oral corticosteroids. Arch Neurol. 2012 Aug; 69(8):1061-3. Goldenholz DM, Wong VS, Bateman LM, Apperson M, Oskarsson B, Akhtar S, Wheelock V. PMID: 22507884.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    26. Cognitive domains that predict time to diagnosis in prodromal Huntington disease. J Neurol Neurosurg Psychiatry. 2012 Jun; 83(6):612-9. Harrington DL, Smith MM, Zhang Y, Carlozzi NE, Paulsen JS, PREDICT-HD Investigators of the Huntington Study Group. PMID: 22451099; PMCID: PMC3812822.
      View in: PubMed   Mentions: 42     Fields:    
    27. 8OHdG as a marker for Huntington disease progression. Neurobiol Dis. 2012 Jun; 46(3):625-34. Long JD, Matson WR, Juhl AR, Leavitt BR, Paulsen JS, PREDICT-HD Investigators and Coordinators of the Huntington Study Group. PMID: 22414782; PMCID: PMC3784019.
      View in: PubMed   Mentions: 35     Fields:    
    28. Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease. Mol Neurobiol. 2012 Feb; 45(1):87-98. Olson SD, Pollock K, Kambal A, Cary W, Mitchell GM, Tempkin J, Stewart H, McGee J, Bauer G, Kim HS, Tempkin T, Wheelock V, Annett G, Dunbar G, Nolta JA. PMID: 22161544; PMCID: PMC3259334.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    29. Predictors of HVOT performance in Parkinson's disease. Appl Neuropsychol. 2011 Jul; 18(3):210-5. Higginson CI, Wheelock VL, Levine D, Pappas CT, Sigvardt KA. PMID: 21846220; PMCID: PMC3199217.
      View in: PubMed   Mentions: 2     Fields:    
    30. Cerebral venous sinus thrombosis presenting with auditory hallucinations and illusions. Cogn Behav Neurol. 2011 Mar; 24(1):40-2. Wong VS, Adamczyk P, Dahlin B, Richman DP, Wheelock V. PMID: 21467920.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    31. Challenges assessing clinical endpoints in early Huntington disease. Mov Disord. 2010 Nov 15; 25(15):2595-603. Paulsen JS, Wang C, Duff K, Barker R, Nance M, Beglinger L, Moser D, Williams JK, Simpson S, Langbehn D, van Kammen DP, PREDICT-HD Investigators of the Huntington Study Group. PMID: 20623772; PMCID: PMC2978744.
      View in: PubMed   Mentions: 35     Fields:    
    32. In their own words: reports of stigma and genetic discrimination by people at risk for Huntington disease in the International RESPOND-HD study. Am J Med Genet B Neuropsychiatr Genet. 2010 Sep; 153B(6):1150-9. Williams JK, Erwin C, Juhl AR, Mengeling M, Bombard Y, Hayden MR, Quaid K, Shoulson I, Taylor S, Paulsen JS, I-RESPOND-HD Investigators of the Huntington Study Group. PMID: 20468062; PMCID: PMC3035936.
      View in: PubMed   Mentions: 22     Fields:    
    33. Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis. Neurobiol Dis. 2010 Dec; 40(3):531-43. Soneson C, Fontes M, Zhou Y, Denisov V, Paulsen JS, Kirik D, Petersén A, Huntington Study Group PREDICT-HD investigators. PMID: 20682340; PMCID: PMC2955781.
      View in: PubMed   Mentions: 31     Fields:    
    34. Perception, experience, and response to genetic discrimination in Huntington disease: the international RESPOND-HD study. Am J Med Genet B Neuropsychiatr Genet. 2010 Jul; 153B(5):1081-93. Erwin C, Williams JK, Juhl AR, Mengeling M, Mills JA, Bombard Y, Hayden MR, Quaid K, Shoulson I, Taylor S, Paulsen JS, I-RESPOND-HD Investigators of the Huntington Study Group. PMID: 20468061; PMCID: PMC3593716.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    35. Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study. Arch Neurol. 2008 Dec; 65(12):1582-9. Huntington Study Group TREND-HD Investigators. PMID: 19064745.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    36. The clinical significance of neuropsychological changes following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. J Clin Exp Neuropsychol. 2009 Jan; 31(1):65-72. Higginson CI, Wheelock VL, Levine D, King DS, Pappas CT, Sigvardt KA. PMID: 18608676.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    37. Cognitive deficits in essential tremor consistent with frontosubcortical dysfunction. J Clin Exp Neuropsychol. 2008 Oct; 30(7):760-5. Higginson CI, Wheelock VL, Levine D, King DS, Pappas CT, Sigvardt KA. PMID: 18608666.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    38. Predictors of diagnosis in Huntington disease. Neurology. 2007 May 15; 68(20):1710-7. Langbehn DR, Paulsen JS, Huntington Study Group. PMID: 17502553.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    39. Recognition memory in Parkinson's disease with and without dementia: evidence inconsistent with the retrieval deficit hypothesis. J Clin Exp Neuropsychol. 2005 May; 27(4):516-28. Higginson CI, Wheelock VL, Carroll KE, Sigvardt KA. PMID: 15962695.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    40. Interrater agreement in the assessment of motor manifestations of Huntington's disease. Mov Disord. 2005 Mar; 20(3):293-7. Hogarth P, Kayson E, Kieburtz K, Marder K, Oakes D, Rosas D, Shoulson I, Wexler NS, Young AB, Zhao H. PMID: 15584032.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    41. Dopamine dependency of cognitive switching and response repetition effects in Parkinson's patients. Neuropsychologia. 2005; 43(14):1990-9. Shook SK, Franz EA, Higginson CI, Wheelock VL, Sigvardt KA. PMID: 16243049.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    42. Temporal evolution of oscillations and synchrony in GPi/muscle pairs in Parkinson's disease. J Neurophysiol. 2005 Mar; 93(3):1569-84. Hurtado JM, Rubchinsky LL, Sigvardt KA, Wheelock VL, Pappas CT. PMID: 15496492.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    43. The relationship between executive function and verbal memory in Parkinson's disease. Brain Cogn. 2003 Aug; 52(3):343-52. Higginson CI, King DS, Levine D, Wheelock VL, Khamphay NO, Sigvardt KA. PMID: 12907179.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    44. Predictors of nursing home placement in Huntington disease. Neurology. 2003 Mar 25; 60(6):998-1001. Wheelock VL, Tempkin T, Marder K, Nance M, Myers RH, Zhao H, Kayson E, Orme C, Shoulson I, Huntington Study Group. PMID: 12654967.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    Vicki's Networks
    Concepts (202)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (25)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California